Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

about

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

Item

http://www.wikidata.org/entity/Q55502644

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

@en

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

@nl

type

Item

label

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

@en

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

@nl

prefLabel

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

@en

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

@nl

P1476

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets

@en

P2093

Gaetano Calì

http://www.w3.org/2001/XMLSchema#string

Lucio Nitsch

http://www.w3.org/2001/XMLSchema#string

Maria Barbato

http://www.w3.org/2001/XMLSchema#string

Maria Nitti

http://www.w3.org/2001/XMLSchema#string

Nunzia Mollo

http://www.w3.org/2001/XMLSchema#string

Rita Cicatiello

http://www.w3.org/2001/XMLSchema#string

Rita Genesio

http://www.w3.org/2001/XMLSchema#string

Simona Paladino

http://www.w3.org/2001/XMLSchema#string

Viviana Sarnataro

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart

Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes.

Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK

The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis

Transcriptional integration of mitochondrial biogenesis

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S10020-018-0004-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonella Izzo

Anna Conti

Ferdinando Bonfiglio

P5008

ScienceSource

P577

2018-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30134785

http://www.w3.org/2001/XMLSchema#string

P921

Down syndrome

Achyolli

P932

6016872

http://www.w3.org/2001/XMLSchema#string